ArticleClinical kidney journal2026
Asymptomatic kidney changes discovered during occupational health screening: age-dependent trends from a large cohort.
Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The urinary albumin-to-creatinine ratio (uACR) and estimated glomerular filtration rate (eGFR) are key biomarkers for asymptomatic detection of chronic kidney disease (CKD), yet their combined use in preventive screening-particularly among young adults-remains uncommon. This study evaluates CKD markers in a large occupational cohort, emphasizing the early renal alterations observed in the 19-30-year age group and their distribution across older age strata. Methods: Between 2021 and 2024, 12 281 healthcare workers aged 19-71 years participated in an occupational health surveillance program at the University Hospital of Bari, Italy. CKD was evaluated using eGFR ( Chronic Kidney disease Epidemiology Collaboration ;CKD-EPI) and uACR from spot urine samples, with classification based on the KDIGO (Kidney Disease: Improving Global Outcomes) guidelines (2024). The results were stratified by age (19-30, 31-60, and >60 years) and comorbidities. Results: Overall, 6.7% of participants met the KDIGO criteria for CKD, with 6.5% exhibiting elevated uACR (>30 mg/g) and 0.2% demonstrating reduced eGFR (<60 mL/min/1.73 m Conclusion: Even in a predominantly healthy working population, one in 20 young adults demonstrated asymptomatic kidney alterations identifiable only through uACR screening. These findings underscore the importance of integrating both uACR and eGFR testing into occupational and preventive health programs to detect mild CKD in all age groups and promote kidney health preservation from early adulthood.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.